

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cell adhesion mediated by integrin (GO:0033627) | 4.34828277 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 4.29924310 |
| 3 | Golgi transport vesicle coating (GO:0048200) | 4.29924310 |
| 4 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.06043393 |
| 5 | cellular potassium ion homeostasis (GO:0030007) | 3.96299893 |
| 6 | synaptic vesicle maturation (GO:0016188) | 3.90982792 |
| 7 | barbed-end actin filament capping (GO:0051016) | 3.86105420 |
| 8 | protein retention in ER lumen (GO:0006621) | 3.84322795 |
| 9 | skin morphogenesis (GO:0043589) | 3.76622157 |
| 10 | sodium ion export (GO:0071436) | 3.73348973 |
| 11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.72721559 |
| 12 | hemidesmosome assembly (GO:0031581) | 3.68166895 |
| 13 | apoptotic cell clearance (GO:0043277) | 3.66852809 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.64495300 |
| 15 | locomotory exploration behavior (GO:0035641) | 3.46972696 |
| 16 | surfactant homeostasis (GO:0043129) | 3.43744794 |
| 17 | synaptic vesicle exocytosis (GO:0016079) | 3.32509638 |
| 18 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.28149595 |
| 19 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.27713063 |
| 20 | glutamate secretion (GO:0014047) | 3.26688692 |
| 21 | layer formation in cerebral cortex (GO:0021819) | 3.25745960 |
| 22 | epithelial cell-cell adhesion (GO:0090136) | 3.23799699 |
| 23 | pinocytosis (GO:0006907) | 3.22044901 |
| 24 | basement membrane organization (GO:0071711) | 3.21389081 |
| 25 | vocalization behavior (GO:0071625) | 3.21350790 |
| 26 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.19339419 |
| 27 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.13942963 |
| 28 | glycosphingolipid catabolic process (GO:0046479) | 3.12375446 |
| 29 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.10961367 |
| 30 | proline transport (GO:0015824) | 3.10770992 |
| 31 | cell-substrate junction assembly (GO:0007044) | 3.10587390 |
| 32 | semaphorin-plexin signaling pathway (GO:0071526) | 3.06009722 |
| 33 | stress fiber assembly (GO:0043149) | 3.03822466 |
| 34 | endodermal cell differentiation (GO:0035987) | 3.03480236 |
| 35 | oligosaccharide catabolic process (GO:0009313) | 3.01588830 |
| 36 | activation of protein kinase A activity (GO:0034199) | 3.01534594 |
| 37 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.97542365 |
| 38 | potassium ion import (GO:0010107) | 2.92893781 |
| 39 | regulation of synapse structural plasticity (GO:0051823) | 2.91629583 |
| 40 | potassium ion homeostasis (GO:0055075) | 2.91509246 |
| 41 | cell communication by electrical coupling (GO:0010644) | 2.89769317 |
| 42 | neurotransmitter secretion (GO:0007269) | 2.88333690 |
| 43 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.88134900 |
| 44 | substrate-dependent cell migration (GO:0006929) | 2.85598858 |
| 45 | regulation of early endosome to late endosome transport (GO:2000641) | 2.85531386 |
| 46 | gamma-aminobutyric acid transport (GO:0015812) | 2.81517028 |
| 47 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.80779878 |
| 48 | glycine transport (GO:0015816) | 2.80549745 |
| 49 | wound healing, spreading of epidermal cells (GO:0035313) | 2.78538969 |
| 50 | response to laminar fluid shear stress (GO:0034616) | 2.75921583 |
| 51 | positive regulation of extracellular matrix organization (GO:1903055) | 2.75193254 |
| 52 | alanine transport (GO:0032328) | 2.75185382 |
| 53 | glycolipid catabolic process (GO:0019377) | 2.74328056 |
| 54 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.73879986 |
| 55 | positive regulation of receptor recycling (GO:0001921) | 2.73352547 |
| 56 | hyaluronan catabolic process (GO:0030214) | 2.72175698 |
| 57 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.71346552 |
| 58 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.71243303 |
| 59 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.70488647 |
| 60 | membrane protein ectodomain proteolysis (GO:0006509) | 2.70045442 |
| 61 | cellular sodium ion homeostasis (GO:0006883) | 2.69202916 |
| 62 | cell communication involved in cardiac conduction (GO:0086065) | 2.68432814 |
| 63 | adherens junction assembly (GO:0034333) | 2.67873578 |
| 64 | positive regulation of synapse maturation (GO:0090129) | 2.67185112 |
| 65 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.67052241 |
| 66 | hypotonic response (GO:0006971) | 2.64524572 |
| 67 | regulation of synaptic vesicle transport (GO:1902803) | 2.63101940 |
| 68 | cortical actin cytoskeleton organization (GO:0030866) | 2.61782442 |
| 69 | cerebellar granule cell differentiation (GO:0021707) | 2.61605155 |
| 70 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.61188577 |
| 71 | protein hydroxylation (GO:0018126) | 2.59623088 |
| 72 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.59592434 |
| 73 | peptidyl-proline hydroxylation (GO:0019511) | 2.58459212 |
| 74 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.56667207 |
| 75 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.56448897 |
| 76 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.56271157 |
| 77 | negative regulation of fibrinolysis (GO:0051918) | 2.55671210 |
| 78 | protein localization to synapse (GO:0035418) | 2.52756042 |
| 79 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.50980414 |
| 80 | dendrite morphogenesis (GO:0048813) | 2.50169160 |
| 81 | negative regulation of fatty acid transport (GO:2000192) | 2.50139461 |
| 82 | vesicle coating (GO:0006901) | 2.49404060 |
| 83 | desmosome organization (GO:0002934) | 2.48894671 |
| 84 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.48556032 |
| 85 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.48521540 |
| 86 | response to pheromone (GO:0019236) | 2.47937703 |
| 87 | chemical homeostasis within a tissue (GO:0048875) | 2.47839831 |
| 88 | wound healing, spreading of cells (GO:0044319) | 2.47577986 |
| 89 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.46558753 |
| 90 | cell-substrate adherens junction assembly (GO:0007045) | 2.46338899 |
| 91 | focal adhesion assembly (GO:0048041) | 2.46338899 |
| 92 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.46130829 |
| 93 | exploration behavior (GO:0035640) | 2.44167355 |
| 94 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.43569658 |
| 95 | neuron cell-cell adhesion (GO:0007158) | 2.43142899 |
| 96 | glomerular visceral epithelial cell development (GO:0072015) | 2.42809039 |
| 97 | iron ion import (GO:0097286) | 2.42521342 |
| 98 | neuronal action potential propagation (GO:0019227) | 2.41215465 |
| 99 | mannose metabolic process (GO:0006013) | 2.40814412 |
| 100 | mesodermal cell differentiation (GO:0048333) | 2.40450094 |
| 101 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.39941270 |
| 102 | response to thyroid hormone (GO:0097066) | 2.39731351 |
| 103 | membrane repolarization (GO:0086009) | 2.39507155 |
| 104 | regulation of extracellular matrix disassembly (GO:0010715) | 2.39102757 |
| 105 | positive regulation of leukocyte degranulation (GO:0043302) | 2.38992156 |
| 106 | neuromuscular process controlling posture (GO:0050884) | 2.38015156 |
| 107 | peptide catabolic process (GO:0043171) | 2.37740821 |
| 108 | membrane raft organization (GO:0031579) | 2.37625390 |
| 109 | protein-lipid complex assembly (GO:0065005) | 2.37364399 |
| 110 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.37130596 |
| 111 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.36949838 |
| 112 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.36931261 |
| 113 | positive regulation of osteoblast proliferation (GO:0033690) | 2.36601661 |
| 114 | cortical cytoskeleton organization (GO:0030865) | 2.36575192 |
| 115 | membrane hyperpolarization (GO:0060081) | 2.36207972 |
| 116 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.36188448 |
| 117 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.35677540 |
| 118 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.35004760 |
| 119 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.34939864 |
| 120 | establishment of nucleus localization (GO:0040023) | 2.33449036 |
| 121 | extracellular matrix disassembly (GO:0022617) | 2.32541610 |
| 122 | plasma lipoprotein particle assembly (GO:0034377) | 2.32442877 |
| 123 | glutamate receptor signaling pathway (GO:0007215) | 2.32083120 |
| 124 | neurotransmitter transport (GO:0006836) | 2.31410817 |
| 125 | endothelial cell chemotaxis (GO:0035767) | 2.31404477 |
| 126 | platelet degranulation (GO:0002576) | 2.31157719 |
| 127 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.30684003 |
| 128 | keratan sulfate catabolic process (GO:0042340) | 2.30391597 |
| 129 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.30183268 |
| 130 | collagen metabolic process (GO:0032963) | 2.29604266 |
| 131 | positive regulation of nuclease activity (GO:0032075) | 2.29372778 |
| 132 | regulation of cholesterol homeostasis (GO:2000188) | 2.28808519 |
| 133 | synaptic transmission, glutamatergic (GO:0035249) | 2.28410044 |
| 134 | cell-cell junction maintenance (GO:0045217) | 2.28052378 |
| 135 | * cellular copper ion homeostasis (GO:0006878) | 2.27885167 |
| 136 | embryonic process involved in female pregnancy (GO:0060136) | 2.27786922 |
| 137 | endocytic recycling (GO:0032456) | 2.27547025 |
| 138 | * neuromuscular process controlling balance (GO:0050885) | 2.27334557 |
| 139 | membrane depolarization during action potential (GO:0086010) | 2.26891685 |
| 140 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.26146408 |
| 141 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.25731252 |
| 142 | neuron-neuron synaptic transmission (GO:0007270) | 2.25523564 |
| 143 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.25084457 |
| 144 | innervation (GO:0060384) | 2.24050440 |
| 145 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.23430154 |
| 146 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.22954633 |
| 147 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.22780314 |
| 148 | synaptic vesicle endocytosis (GO:0048488) | 2.22659928 |
| 149 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.22560997 |
| 150 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.21932543 |
| 151 | axonal fasciculation (GO:0007413) | 2.21551276 |
| 152 | low-density lipoprotein particle clearance (GO:0034383) | 2.21409103 |
| 153 | prepulse inhibition (GO:0060134) | 2.21258932 |
| 154 | regulation of extracellular matrix organization (GO:1903053) | 2.20909814 |
| 155 | neuron recognition (GO:0008038) | 2.20902287 |
| 156 | ceramide catabolic process (GO:0046514) | 2.20898505 |
| 157 | positive regulation of phagocytosis (GO:0050766) | 2.20784402 |
| 158 | response to auditory stimulus (GO:0010996) | 2.20670027 |
| 159 | glomerular epithelial cell development (GO:0072310) | 2.20241110 |
| 160 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.19611615 |
| 161 | embryo implantation (GO:0007566) | 2.19588740 |
| 162 | collagen catabolic process (GO:0030574) | 2.19442483 |
| 163 | phospholipid efflux (GO:0033700) | 2.18676262 |
| 164 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.18330648 |
| 165 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.18150489 |
| 166 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.17886350 |
| 167 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.17734064 |
| 168 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.17342746 |
| 169 | regulation of cholesterol esterification (GO:0010872) | 2.16656303 |
| 170 | long term synaptic depression (GO:0060292) | 2.15701196 |
| 171 | dendritic spine morphogenesis (GO:0060997) | 2.15254327 |
| 172 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.14652915 |
| 173 | regulation of neurotransmitter levels (GO:0001505) | 2.13859433 |
| 174 | positive regulation of potassium ion transport (GO:0043268) | 2.13531420 |
| 175 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.13095336 |
| 176 | positive regulation of macrophage cytokine production (GO:0060907) | 2.11595876 |
| 177 | protein localization to endosome (GO:0036010) | 2.10501041 |
| 178 | long-term memory (GO:0007616) | 2.10222031 |
| 179 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.09155851 |
| 180 | * mating behavior (GO:0007617) | 2.08011584 |
| 181 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.07991630 |
| 182 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.07771004 |
| 183 | synapse assembly (GO:0007416) | 2.07749339 |
| 184 | vesicle transport along microtubule (GO:0047496) | 2.07732336 |
| 185 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.07564045 |
| 186 | regulation of postsynaptic membrane potential (GO:0060078) | 2.04694626 |
| 187 | regulation of ARF protein signal transduction (GO:0032012) | 2.03780987 |
| 188 | long-term synaptic potentiation (GO:0060291) | 2.02900663 |
| 189 | protein targeting to plasma membrane (GO:0072661) | 2.02858754 |
| 190 | synapse organization (GO:0050808) | 2.02619295 |
| 191 | positive regulation of sodium ion transport (GO:0010765) | 2.02503517 |
| 192 | clathrin coat assembly (GO:0048268) | 2.02457223 |
| 193 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.01880313 |
| 194 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.00620841 |
| 195 | regulation of neurotransmitter secretion (GO:0046928) | 2.00484303 |
| 196 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.00469292 |
| 197 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 1.98904911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.37605775 |
| 2 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.70360748 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.69256662 |
| 4 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.68310814 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.48882877 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.34447350 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.29334470 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.29334470 |
| 9 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.22880925 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.19670382 |
| 11 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.18493861 |
| 12 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.17685419 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.10936946 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.05017778 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.04942335 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.04278803 |
| 17 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02789963 |
| 18 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.02201239 |
| 19 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.01450809 |
| 20 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.99751067 |
| 21 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.95414654 |
| 22 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.92222638 |
| 23 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.92020808 |
| 24 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.88144393 |
| 25 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.86745304 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.85898931 |
| 27 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.81539953 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.77797597 |
| 29 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.77661980 |
| 30 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.75793824 |
| 31 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.72093703 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.70748182 |
| 33 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.70354894 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.68913439 |
| 35 | * ZNF263_19887448_ChIP-Seq_K562_Human | 1.68530746 |
| 36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.64030762 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.61087541 |
| 38 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60995422 |
| 39 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.60566875 |
| 40 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.60005737 |
| 41 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.59517007 |
| 42 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.56000113 |
| 43 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.54547906 |
| 44 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.54547906 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.54202104 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.54104258 |
| 47 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.53972971 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.53805411 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53607680 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.53587898 |
| 51 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.53329267 |
| 52 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.53062807 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53010855 |
| 54 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52659174 |
| 55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50205294 |
| 56 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.50070196 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.50031730 |
| 58 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.45738469 |
| 59 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.45707684 |
| 60 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43221765 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.42433302 |
| 62 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.41953863 |
| 63 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.41775707 |
| 64 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.38516126 |
| 65 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37133032 |
| 66 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.36916284 |
| 67 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36097954 |
| 68 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.36040632 |
| 69 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.34638713 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33684780 |
| 71 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.33580516 |
| 72 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.33363832 |
| 73 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.33256089 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.32805448 |
| 75 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.32554580 |
| 76 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.31695182 |
| 77 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.31080878 |
| 78 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.29713195 |
| 79 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.27841942 |
| 80 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.27841942 |
| 81 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27586193 |
| 82 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.26003258 |
| 83 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.24150745 |
| 84 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.23617132 |
| 85 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.22213475 |
| 86 | ATF3_27146783_Chip-Seq_COLON_Human | 1.22077409 |
| 87 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21498414 |
| 88 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.21474447 |
| 89 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21211755 |
| 90 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.20144037 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.19947189 |
| 92 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18984383 |
| 93 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18792693 |
| 94 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.18552028 |
| 95 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16888911 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15279513 |
| 97 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.14889203 |
| 98 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.13626394 |
| 99 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13173715 |
| 100 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.12981738 |
| 101 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.12494970 |
| 102 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.11402118 |
| 103 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.10719531 |
| 104 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10640370 |
| 105 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.09936023 |
| 106 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.08664205 |
| 107 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.08346079 |
| 108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.07963843 |
| 109 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07361742 |
| 110 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07014441 |
| 111 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06861435 |
| 112 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.06446763 |
| 113 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.06063885 |
| 114 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05591448 |
| 115 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05385729 |
| 116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05133429 |
| 117 | AR_19668381_ChIP-Seq_PC3_Human | 1.04394417 |
| 118 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.03608980 |
| 119 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.03181611 |
| 120 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02871001 |
| 121 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.02143769 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.02143769 |
| 123 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.01768189 |
| 124 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.01692041 |
| 125 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01656759 |
| 126 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.01564689 |
| 127 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01353119 |
| 128 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.01264548 |
| 129 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00841354 |
| 130 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00695208 |
| 131 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.00686743 |
| 132 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.00500016 |
| 133 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.99730870 |
| 134 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99531457 |
| 135 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99153357 |
| 136 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.98932468 |
| 137 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98796012 |
| 138 | RXR_22108803_ChIP-Seq_LS180_Human | 0.98247389 |
| 139 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98240699 |
| 140 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.98119040 |
| 141 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97831778 |
| 142 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.96916508 |
| 143 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96361962 |
| 144 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96289089 |
| 145 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.94738277 |
| 146 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94028979 |
| 147 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.93479616 |
| 148 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93446844 |
| 149 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92930442 |
| 150 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91809056 |
| 151 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91196290 |
| 152 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90883694 |
| 153 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90433566 |
| 154 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.90412473 |
| 155 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90358891 |
| 156 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.89044379 |
| 157 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.88438884 |
| 158 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.87385967 |
| 159 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87325126 |
| 160 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.86150228 |
| 161 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85779611 |
| 162 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.85322975 |
| 163 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84805389 |
| 164 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84600523 |
| 165 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84337942 |
| 166 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.84031034 |
| 167 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83904847 |
| 168 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.82462312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.11673054 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.79856646 |
| 3 | MP0003566_abnormal_cell_adhesion | 3.43965959 |
| 4 | MP0009840_abnormal_foam_cell | 3.09869839 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 2.73291803 |
| 6 | * MP0003635_abnormal_synaptic_transmissio | 2.70072728 |
| 7 | MP0009046_muscle_twitch | 2.45948301 |
| 8 | MP0004270_analgesia | 2.44558886 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.43982653 |
| 10 | MP0004858_abnormal_nervous_system | 2.34746099 |
| 11 | MP0003329_amyloid_beta_deposits | 2.25280167 |
| 12 | MP0003880_abnormal_central_pattern | 2.18148457 |
| 13 | MP0002064_seizures | 2.14139189 |
| 14 | MP0003091_abnormal_cell_migration | 2.13649452 |
| 15 | MP0004130_abnormal_muscle_cell | 2.11631622 |
| 16 | MP0009745_abnormal_behavioral_response | 2.03561740 |
| 17 | MP0003690_abnormal_glial_cell | 2.01120577 |
| 18 | MP0001849_ear_inflammation | 1.98084572 |
| 19 | MP0002063_abnormal_learning/memory/cond | 1.97026170 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 1.96279153 |
| 21 | MP0000013_abnormal_adipose_tissue | 1.94628855 |
| 22 | MP0005409_darkened_coat_color | 1.88615391 |
| 23 | MP0005623_abnormal_meninges_morphology | 1.86133548 |
| 24 | MP0002272_abnormal_nervous_system | 1.85937606 |
| 25 | MP0002909_abnormal_adrenal_gland | 1.85504656 |
| 26 | MP0005670_abnormal_white_adipose | 1.85007442 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.84204481 |
| 28 | MP0005023_abnormal_wound_healing | 1.82049663 |
| 29 | MP0006054_spinal_hemorrhage | 1.81912535 |
| 30 | MP0005451_abnormal_body_composition | 1.80481399 |
| 31 | MP0002734_abnormal_mechanical_nocicepti | 1.79337215 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.77081666 |
| 33 | MP0005076_abnormal_cell_differentiation | 1.75775755 |
| 34 | MP0004885_abnormal_endolymph | 1.74332975 |
| 35 | MP0005167_abnormal_blood-brain_barrier | 1.72895661 |
| 36 | MP0004264_abnormal_extraembryonic_tissu | 1.71431251 |
| 37 | MP0001486_abnormal_startle_reflex | 1.71082299 |
| 38 | MP0003279_aneurysm | 1.70648353 |
| 39 | MP0004272_abnormal_basement_membrane | 1.70552664 |
| 40 | MP0001501_abnormal_sleep_pattern | 1.62678361 |
| 41 | MP0003453_abnormal_keratinocyte_physiol | 1.58394754 |
| 42 | MP0003828_pulmonary_edema | 1.56858210 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.56362417 |
| 44 | MP0008569_lethality_at_weaning | 1.55985551 |
| 45 | MP0002090_abnormal_vision | 1.55472626 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.54731075 |
| 47 | MP0002896_abnormal_bone_mineralization | 1.54384385 |
| 48 | MP0008260_abnormal_autophagy | 1.53911673 |
| 49 | MP0002572_abnormal_emotion/affect_behav | 1.53568429 |
| 50 | MP0003303_peritoneal_inflammation | 1.53300649 |
| 51 | MP0000751_myopathy | 1.52529764 |
| 52 | MP0002822_catalepsy | 1.52095800 |
| 53 | MP0001984_abnormal_olfaction | 1.50240867 |
| 54 | MP0005551_abnormal_eye_electrophysiolog | 1.49996405 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.45027676 |
| 56 | MP0000858_altered_metastatic_potential | 1.41881277 |
| 57 | MP0001915_intracranial_hemorrhage | 1.41413692 |
| 58 | MP0004782_abnormal_surfactant_physiolog | 1.40173580 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.39227855 |
| 60 | MP0000604_amyloidosis | 1.38654729 |
| 61 | MP0000537_abnormal_urethra_morphology | 1.38017225 |
| 62 | MP0002254_reproductive_system_inflammat | 1.37816315 |
| 63 | MP0000767_abnormal_smooth_muscle | 1.37756609 |
| 64 | MP0002733_abnormal_thermal_nociception | 1.37672362 |
| 65 | MP0005164_abnormal_response_to | 1.36869710 |
| 66 | MP0000003_abnormal_adipose_tissue | 1.36585294 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.36463539 |
| 68 | MP0003633_abnormal_nervous_system | 1.36440032 |
| 69 | MP0005666_abnormal_adipose_tissue | 1.34062167 |
| 70 | MP0005165_increased_susceptibility_to | 1.33106404 |
| 71 | MP0005423_abnormal_somatic_nervous | 1.32900031 |
| 72 | * MP0002067_abnormal_sensory_capabilities | 1.32604496 |
| 73 | MP0002736_abnormal_nociception_after | 1.31347830 |
| 74 | MP0010329_abnormal_lipoprotein_level | 1.28885294 |
| 75 | MP0005375_adipose_tissue_phenotype | 1.28420866 |
| 76 | MP0010368_abnormal_lymphatic_system | 1.27253375 |
| 77 | MP0008438_abnormal_cutaneous_collagen | 1.27248767 |
| 78 | MP0002837_dystrophic_cardiac_calcinosis | 1.26680629 |
| 79 | MP0001440_abnormal_grooming_behavior | 1.23974186 |
| 80 | MP0003941_abnormal_skin_development | 1.23564885 |
| 81 | MP0004215_abnormal_myocardial_fiber | 1.22811798 |
| 82 | MP0003045_fibrosis | 1.21159066 |
| 83 | MP0003634_abnormal_glial_cell | 1.20132335 |
| 84 | MP0001970_abnormal_pain_threshold | 1.19874655 |
| 85 | MP0003950_abnormal_plasma_membrane | 1.18721176 |
| 86 | MP0002184_abnormal_innervation | 1.18310962 |
| 87 | MP0002060_abnormal_skin_morphology | 1.17387008 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 1.16421690 |
| 89 | MP0001502_abnormal_circadian_rhythm | 1.15834457 |
| 90 | MP0003631_nervous_system_phenotype | 1.15686483 |
| 91 | MP0004510_myositis | 1.15258155 |
| 92 | MP0006082_CNS_inflammation | 1.13956690 |
| 93 | MP0000920_abnormal_myelination | 1.13571352 |
| 94 | MP0002796_impaired_skin_barrier | 1.10776622 |
| 95 | MP0004924_abnormal_behavior | 1.10616471 |
| 96 | MP0005386_behavior/neurological_phenoty | 1.10616471 |
| 97 | MP0008004_abnormal_stomach_pH | 1.10069645 |
| 98 | MP0003632_abnormal_nervous_system | 1.09863772 |
| 99 | MP0000778_abnormal_nervous_system | 1.09381683 |
| 100 | MP0003075_altered_response_to | 1.08433401 |
| 101 | MP0001533_abnormal_skeleton_physiology | 1.08010589 |
| 102 | MP0005275_abnormal_skin_tensile | 1.06538347 |
| 103 | MP0001177_atelectasis | 1.05706193 |
| 104 | MP0000343_altered_response_to | 1.05609405 |
| 105 | MP0004036_abnormal_muscle_relaxation | 1.04936864 |
| 106 | MP0004811_abnormal_neuron_physiology | 1.04786205 |
| 107 | MP0004084_abnormal_cardiac_muscle | 1.02695098 |
| 108 | * MP0002882_abnormal_neuron_morphology | 1.01842941 |
| 109 | MP0003879_abnormal_hair_cell | 1.01280074 |
| 110 | MP0008961_abnormal_basal_metabolism | 1.00242223 |
| 111 | MP0005535_abnormal_body_temperature | 0.99187348 |
| 112 | MP0002229_neurodegeneration | 0.98914798 |
| 113 | MP0003436_decreased_susceptibility_to | 0.98226588 |
| 114 | MP0010030_abnormal_orbit_morphology | 0.97690164 |
| 115 | MP0000955_abnormal_spinal_cord | 0.96306647 |
| 116 | * MP0002066_abnormal_motor_capabilities/c | 0.95110095 |
| 117 | MP0006138_congestive_heart_failure | 0.94969351 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.94106979 |
| 119 | MP0004947_skin_inflammation | 0.93235892 |
| 120 | MP0001614_abnormal_blood_vessel | 0.93034939 |
| 121 | MP0002557_abnormal_social/conspecific_i | 0.92950335 |
| 122 | MP0009384_cardiac_valve_regurgitation | 0.92210120 |
| 123 | MP0005508_abnormal_skeleton_morphology | 0.92158921 |
| 124 | MP0005197_abnormal_uvea_morphology | 0.90463404 |
| 125 | MP0003448_altered_tumor_morphology | 0.90054537 |
| 126 | MP0001958_emphysema | 0.89946790 |
| 127 | MP0005464_abnormal_platelet_physiology | 0.88478948 |
| 128 | MP0002118_abnormal_lipid_homeostasis | 0.87487764 |
| 129 | MP0010678_abnormal_skin_adnexa | 0.87395166 |
| 130 | MP0003191_abnormal_cellular_cholesterol | 0.87389111 |
| 131 | MP0005620_abnormal_muscle_contractility | 0.87241174 |
| 132 | MP0000534_abnormal_ureter_morphology | 0.86380687 |
| 133 | MP0008775_abnormal_heart_ventricle | 0.86030514 |
| 134 | MP0004233_abnormal_muscle_weight | 0.85799208 |
| 135 | MP0002295_abnormal_pulmonary_circulatio | 0.85195297 |
| 136 | MP0003283_abnormal_digestive_organ | 0.85096676 |
| 137 | MP0002971_abnormal_brown_adipose | 0.84142696 |
| 138 | MP0004085_abnormal_heartbeat | 0.81968196 |
| 139 | MP0009278_abnormal_bone_marrow | 0.81060982 |
| 140 | MP0004883_abnormal_blood_vessel | 0.80250460 |
| 141 | MP0005390_skeleton_phenotype | 0.79649996 |
| 142 | MP0001542_abnormal_bone_strength | 0.79523403 |
| 143 | MP0005388_respiratory_system_phenotype | 0.79365052 |
| 144 | MP0002133_abnormal_respiratory_system | 0.79365052 |
| 145 | MP0001299_abnormal_eye_distance/ | 0.77966670 |
| 146 | MP0010386_abnormal_urinary_bladder | 0.77893934 |
| 147 | MP0005621_abnormal_cell_physiology | 0.77017074 |
| 148 | MP0002139_abnormal_hepatobiliary_system | 0.76409783 |
| 149 | MP0003115_abnormal_respiratory_system | 0.76175088 |
| 150 | MP0008874_decreased_physiological_sensi | 0.75985563 |
| 151 | MP0002925_abnormal_cardiovascular_devel | 0.75626315 |
| 152 | MP0002972_abnormal_cardiac_muscle | 0.75399787 |
| 153 | MP0004145_abnormal_muscle_electrophysio | 0.75282335 |
| 154 | MP0003183_abnormal_peptide_metabolism | 0.73896242 |
| 155 | MP0002419_abnormal_innate_immunity | 0.73785206 |
| 156 | MP0004043_abnormal_pH_regulation | 0.73536119 |
| 157 | MP0008872_abnormal_physiological_respon | 0.73440170 |
| 158 | MP0001879_abnormal_lymphatic_vessel | 0.73003369 |
| 159 | MP0000762_abnormal_tongue_morphology | 0.72032289 |
| 160 | MP0001216_abnormal_epidermal_layer | 0.71741251 |
| 161 | MP0005501_abnormal_skin_physiology | 0.70697134 |
| 162 | MP0005595_abnormal_vascular_smooth | 0.69456242 |
| 163 | MP0004484_altered_response_of | 0.69080284 |
| 164 | MP0003172_abnormal_lysosome_physiology | 0.68704953 |
| 165 | MP0003795_abnormal_bone_structure | 0.68688432 |
| 166 | MP0000249_abnormal_blood_vessel | 0.67699369 |
| 167 | MP0010630_abnormal_cardiac_muscle | 0.66063316 |
| 168 | MP0005083_abnormal_biliary_tract | 0.65919262 |
| 169 | MP0000681_abnormal_thyroid_gland | 0.65479535 |
| 170 | MP0000467_abnormal_esophagus_morphology | 0.63578908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protrusio acetabuli (HP:0003179) | 4.34086321 |
| 2 | Action tremor (HP:0002345) | 4.08623761 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.06228610 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.06228610 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.06228610 |
| 6 | Premature rupture of membranes (HP:0001788) | 3.97708771 |
| 7 | Myokymia (HP:0002411) | 3.68856931 |
| 8 | Focal motor seizures (HP:0011153) | 3.43334968 |
| 9 | Focal seizures (HP:0007359) | 3.39938951 |
| 10 | Vertebral compression fractures (HP:0002953) | 3.31913836 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.31156551 |
| 12 | Dysostosis multiplex (HP:0000943) | 3.26097332 |
| 13 | Neurofibrillary tangles (HP:0002185) | 3.23399323 |
| 14 | Amyloidosis (HP:0011034) | 3.18187895 |
| 15 | Cervical subluxation (HP:0003308) | 3.10465747 |
| 16 | Visual hallucinations (HP:0002367) | 3.06099071 |
| 17 | Cerebral inclusion bodies (HP:0100314) | 3.05634246 |
| 18 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.90702707 |
| 19 | Mucopolysacchariduria (HP:0008155) | 2.90702707 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 2.84728536 |
| 21 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.77509257 |
| 22 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.77509257 |
| 23 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.77509257 |
| 24 | Central scotoma (HP:0000603) | 2.75421767 |
| 25 | Myocardial infarction (HP:0001658) | 2.73862608 |
| 26 | Intention tremor (HP:0002080) | 2.73566053 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 2.72300002 |
| 28 | Atonic seizures (HP:0010819) | 2.71686429 |
| 29 | Broad metatarsal (HP:0001783) | 2.69337208 |
| 30 | Flat acetabular roof (HP:0003180) | 2.68784027 |
| 31 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.66946996 |
| 32 | Osteolytic defects of the hand bones (HP:0009699) | 2.66946996 |
| 33 | Atrophic scars (HP:0001075) | 2.65413865 |
| 34 | Interstitial pulmonary disease (HP:0006530) | 2.64939556 |
| 35 | Loss of speech (HP:0002371) | 2.59439683 |
| 36 | Ankle clonus (HP:0011448) | 2.57537907 |
| 37 | Short nail (HP:0001799) | 2.57268670 |
| 38 | Hemiplegia (HP:0002301) | 2.52966523 |
| 39 | Abnormality of the lower motor neuron (HP:0002366) | 2.52447307 |
| 40 | Dysdiadochokinesis (HP:0002075) | 2.50328901 |
| 41 | Absence seizures (HP:0002121) | 2.47551920 |
| 42 | Generalized tonic-clonic seizures (HP:0002069) | 2.45653935 |
| 43 | Epileptic encephalopathy (HP:0200134) | 2.45423094 |
| 44 | Nuclear cataract (HP:0100018) | 2.43210064 |
| 45 | Dysmetric saccades (HP:0000641) | 2.40958060 |
| 46 | Insidious onset (HP:0003587) | 2.36440914 |
| 47 | Termporal pattern (HP:0011008) | 2.36440914 |
| 48 | Scanning speech (HP:0002168) | 2.36109180 |
| 49 | Torticollis (HP:0000473) | 2.35392937 |
| 50 | Depression (HP:0000716) | 2.33754147 |
| 51 | Postural instability (HP:0002172) | 2.33539422 |
| 52 | Ventricular fibrillation (HP:0001663) | 2.31791930 |
| 53 | Wormian bones (HP:0002645) | 2.31277947 |
| 54 | Hyperacusis (HP:0010780) | 2.28527724 |
| 55 | Febrile seizures (HP:0002373) | 2.27048897 |
| 56 | Abnormal eating behavior (HP:0100738) | 2.25858948 |
| 57 | Turricephaly (HP:0000262) | 2.22906346 |
| 58 | Pheochromocytoma (HP:0002666) | 2.21339487 |
| 59 | Mitral stenosis (HP:0001718) | 2.20808272 |
| 60 | Upper limb amyotrophy (HP:0009129) | 2.17656910 |
| 61 | Distal upper limb amyotrophy (HP:0007149) | 2.17656910 |
| 62 | Aortic dissection (HP:0002647) | 2.16936659 |
| 63 | Scotoma (HP:0000575) | 2.15315563 |
| 64 | Difficulty running (HP:0009046) | 2.15083834 |
| 65 | Aneurysm (HP:0002617) | 2.14019198 |
| 66 | Dysmetria (HP:0001310) | 2.13681057 |
| 67 | Dialeptic seizures (HP:0011146) | 2.12645490 |
| 68 | Hand muscle atrophy (HP:0009130) | 2.11010690 |
| 69 | Abnormality of macular pigmentation (HP:0008002) | 2.07771108 |
| 70 | Back pain (HP:0003418) | 2.07276179 |
| 71 | Broad face (HP:0000283) | 2.07178384 |
| 72 | Distal lower limb muscle weakness (HP:0009053) | 2.07173016 |
| 73 | Postural tremor (HP:0002174) | 2.06294386 |
| 74 | Impaired social interactions (HP:0000735) | 2.06189647 |
| 75 | Abnormal social behavior (HP:0012433) | 2.06189647 |
| 76 | Distal lower limb amyotrophy (HP:0008944) | 2.05816973 |
| 77 | Cerebral aneurysm (HP:0004944) | 2.05772737 |
| 78 | Bronchomalacia (HP:0002780) | 2.05768576 |
| 79 | Truncal ataxia (HP:0002078) | 2.04570420 |
| 80 | Abnormality of macrophages (HP:0004311) | 2.04391671 |
| 81 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.03829461 |
| 82 | Apathy (HP:0000741) | 2.03600660 |
| 83 | Abnormality of the acetabulum (HP:0003170) | 2.03253600 |
| 84 | Blue sclerae (HP:0000592) | 2.01735020 |
| 85 | Mutism (HP:0002300) | 2.01506927 |
| 86 | Aortic aneurysm (HP:0004942) | 2.01065001 |
| 87 | Axonal loss (HP:0003447) | 2.00944618 |
| 88 | Fragile skin (HP:0001030) | 2.00477914 |
| 89 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.99336096 |
| 90 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.96787015 |
| 91 | Aplasia of the phalanges of the hand (HP:0009802) | 1.96787015 |
| 92 | Aplasia involving bones of the extremities (HP:0009825) | 1.96787015 |
| 93 | Genetic anticipation (HP:0003743) | 1.96544393 |
| 94 | Abnormality of carpal bone ossification (HP:0006257) | 1.95744534 |
| 95 | Hemorrhage of the eye (HP:0011885) | 1.95073604 |
| 96 | Systemic lupus erythematosus (HP:0002725) | 1.94918192 |
| 97 | Gaze-evoked nystagmus (HP:0000640) | 1.94901985 |
| 98 | Lower limb muscle weakness (HP:0007340) | 1.94348729 |
| 99 | Increased variability in muscle fiber diameter (HP:0003557) | 1.93257019 |
| 100 | Increased cerebral lipofuscin (HP:0011813) | 1.92240105 |
| 101 | Anxiety (HP:0000739) | 1.91666578 |
| 102 | Diminished motivation (HP:0000745) | 1.91516889 |
| 103 | Ankle contracture (HP:0006466) | 1.91161555 |
| 104 | Shallow orbits (HP:0000586) | 1.90867578 |
| 105 | Skin nodule (HP:0200036) | 1.89052641 |
| 106 | Focal dystonia (HP:0004373) | 1.88886144 |
| 107 | Spinal rigidity (HP:0003306) | 1.88825938 |
| 108 | Hemiparesis (HP:0001269) | 1.88724930 |
| 109 | Cardiovascular calcification (HP:0011915) | 1.88182109 |
| 110 | Status epilepticus (HP:0002133) | 1.88158827 |
| 111 | Abnormality of the corticospinal tract (HP:0002492) | 1.87899678 |
| 112 | Poor eye contact (HP:0000817) | 1.87783876 |
| 113 | Craniofacial dystonia (HP:0012179) | 1.87575255 |
| 114 | Neuronal loss in central nervous system (HP:0002529) | 1.87370062 |
| 115 | Rapidly progressive (HP:0003678) | 1.86269248 |
| 116 | Coxa vara (HP:0002812) | 1.85430879 |
| 117 | Oligomenorrhea (HP:0000876) | 1.85182730 |
| 118 | Bone pain (HP:0002653) | 1.85065956 |
| 119 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.84190138 |
| 120 | Congenital stationary night blindness (HP:0007642) | 1.84035708 |
| 121 | Abnormal ossification of hand bones (HP:0005921) | 1.83924928 |
| 122 | Prolonged QT interval (HP:0001657) | 1.83269747 |
| 123 | Pigmentary retinal degeneration (HP:0001146) | 1.82308437 |
| 124 | Ulnar bowing (HP:0003031) | 1.80734767 |
| 125 | Syncope (HP:0001279) | 1.80355777 |
| 126 | Hypercortisolism (HP:0001578) | 1.80281553 |
| 127 | Bladder diverticulum (HP:0000015) | 1.79786393 |
| 128 | Hammertoe (HP:0001765) | 1.79761401 |
| 129 | Vascular calcification (HP:0004934) | 1.79654603 |
| 130 | Urinary urgency (HP:0000012) | 1.79610834 |
| 131 | Abnormality of the common coagulation pathway (HP:0010990) | 1.79294861 |
| 132 | Upper motor neuron abnormality (HP:0002127) | 1.78564583 |
| 133 | Spondylolisthesis (HP:0003302) | 1.78245229 |
| 134 | Exercise-induced myalgia (HP:0003738) | 1.77339029 |
| 135 | Resting tremor (HP:0002322) | 1.77328953 |
| 136 | Cerebral hemorrhage (HP:0001342) | 1.77209393 |
| 137 | Right ventricular cardiomyopathy (HP:0011663) | 1.77166834 |
| 138 | Increased connective tissue (HP:0009025) | 1.76832128 |
| 139 | Spastic gait (HP:0002064) | 1.76684347 |
| 140 | Hypoventilation (HP:0002791) | 1.76158222 |
| 141 | Abnormality of complement system (HP:0005339) | 1.75425688 |
| 142 | Lymphangioma (HP:0100764) | 1.75113185 |
| 143 | Natal tooth (HP:0000695) | 1.75069646 |
| 144 | Onion bulb formation (HP:0003383) | 1.74901953 |
| 145 | Achilles tendon contracture (HP:0001771) | 1.74622847 |
| 146 | Acanthosis nigricans (HP:0000956) | 1.74320733 |
| 147 | Esophageal varix (HP:0002040) | 1.74237374 |
| 148 | Ovoid vertebral bodies (HP:0003300) | 1.74037965 |
| 149 | Hyporeflexia of lower limbs (HP:0002600) | 1.73227654 |
| 150 | Mitral valve prolapse (HP:0001634) | 1.72588985 |
| 151 | Ankyloglossia (HP:0010296) | 1.72384938 |
| 152 | Mitral regurgitation (HP:0001653) | 1.72266191 |
| 153 | Neuroendocrine neoplasm (HP:0100634) | 1.72240245 |
| 154 | Tetraparesis (HP:0002273) | 1.71070613 |
| 155 | Synostosis involving the elbow (HP:0003938) | 1.70850376 |
| 156 | Humeroradial synostosis (HP:0003041) | 1.70850376 |
| 157 | Deep venous thrombosis (HP:0002625) | 1.70816202 |
| 158 | Dilatation of the ascending aorta (HP:0005111) | 1.70455296 |
| 159 | Asymmetric septal hypertrophy (HP:0001670) | 1.70335489 |
| 160 | Advanced eruption of teeth (HP:0006288) | 1.69568746 |
| 161 | Pathologic fracture (HP:0002756) | 1.69399080 |
| 162 | Abnormality of the Achilles tendon (HP:0005109) | 1.68734687 |
| 163 | Joint stiffness (HP:0001387) | 1.68142680 |
| 164 | Insomnia (HP:0100785) | 1.68071483 |
| 165 | Enlarged penis (HP:0000040) | 1.67358835 |
| 166 | Subcapsular cataract (HP:0000523) | 1.67169299 |
| 167 | Buphthalmos (HP:0000557) | 1.67088454 |
| 168 | Megalencephaly (HP:0001355) | 1.66238854 |
| 169 | Arnold-Chiari malformation (HP:0002308) | 1.66155115 |
| 170 | Disproportionate tall stature (HP:0001519) | 1.65878209 |
| 171 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.65779927 |
| 172 | Thin bony cortex (HP:0002753) | 1.65639379 |
| 173 | Abnormality of dentin (HP:0010299) | 1.65385264 |
| 174 | Lower limb amyotrophy (HP:0007210) | 1.63533191 |
| 175 | Xanthomatosis (HP:0000991) | 1.63200541 |
| 176 | Neonatal short-limb short stature (HP:0008921) | 1.61084269 |
| 177 | Abnormality of binocular vision (HP:0011514) | 1.60981726 |
| 178 | Diplopia (HP:0000651) | 1.60981726 |
| 179 | Macroorchidism (HP:0000053) | 1.60880270 |
| 180 | Arterial tortuosity (HP:0005116) | 1.60653598 |
| 181 | Sudden death (HP:0001699) | 1.60554699 |
| 182 | Vascular tortuosity (HP:0004948) | 1.59670705 |
| 183 | Hyperextensible skin (HP:0000974) | 1.59629995 |
| 184 | Abnormality of the lumbar spine (HP:0100712) | 1.59444424 |
| 185 | Clonus (HP:0002169) | 1.58799545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 3.45617028 |
| 2 | RIPK1 | 2.88733293 |
| 3 | MST1R | 2.77172636 |
| 4 | MAP3K9 | 2.57401297 |
| 5 | ERN1 | 2.53803200 |
| 6 | DAPK2 | 2.33149565 |
| 7 | IRAK3 | 2.26079993 |
| 8 | NTRK3 | 2.23738507 |
| 9 | LMTK2 | 2.23506948 |
| 10 | PAK4 | 2.23138671 |
| 11 | PAK6 | 2.12724495 |
| 12 | MAP3K4 | 2.12451631 |
| 13 | NTRK1 | 2.07409934 |
| 14 | EPHA4 | 1.98402344 |
| 15 | TRIB3 | 1.95323803 |
| 16 | TGFBR2 | 1.94597837 |
| 17 | KSR2 | 1.91238395 |
| 18 | MET | 1.86381026 |
| 19 | MINK1 | 1.85039695 |
| 20 | CDK12 | 1.82271056 |
| 21 | TESK1 | 1.78653979 |
| 22 | CAMK1G | 1.77382204 |
| 23 | MARK1 | 1.75751716 |
| 24 | PHKG1 | 1.71687443 |
| 25 | PHKG2 | 1.71687443 |
| 26 | CAMK1D | 1.69218226 |
| 27 | MAP2K4 | 1.61217364 |
| 28 | PRKD3 | 1.60947302 |
| 29 | CAMKK1 | 1.57093397 |
| 30 | FER | 1.55480176 |
| 31 | FGFR4 | 1.50649045 |
| 32 | STK38 | 1.45979781 |
| 33 | MOS | 1.45872662 |
| 34 | ERBB4 | 1.41669965 |
| 35 | NTRK2 | 1.36862204 |
| 36 | MAP3K2 | 1.35934566 |
| 37 | MAP3K3 | 1.35437654 |
| 38 | LATS1 | 1.32863814 |
| 39 | SMG1 | 1.31760113 |
| 40 | CAMKK2 | 1.30658851 |
| 41 | SIK1 | 1.30177593 |
| 42 | RET | 1.30004338 |
| 43 | TIE1 | 1.29917242 |
| 44 | FGFR2 | 1.25720841 |
| 45 | PAK3 | 1.21995463 |
| 46 | MAP2K3 | 1.19420027 |
| 47 | LATS2 | 1.17690943 |
| 48 | SGK494 | 1.17153128 |
| 49 | SGK223 | 1.17153128 |
| 50 | TYRO3 | 1.16148558 |
| 51 | EPHB1 | 1.15744247 |
| 52 | NEK9 | 1.15626378 |
| 53 | WNK1 | 1.13962776 |
| 54 | STK39 | 1.13666161 |
| 55 | MAP2K7 | 1.13427121 |
| 56 | OXSR1 | 1.11598161 |
| 57 | CDK5 | 1.08971333 |
| 58 | PDGFRA | 1.07326242 |
| 59 | LIMK1 | 1.06847882 |
| 60 | PRKCH | 1.04856982 |
| 61 | EEF2K | 1.02367447 |
| 62 | DDR2 | 1.01045890 |
| 63 | EPHB2 | 0.94938948 |
| 64 | MTOR | 0.94663487 |
| 65 | GRK5 | 0.93800737 |
| 66 | MAP3K6 | 0.93169424 |
| 67 | NEK1 | 0.93041984 |
| 68 | SGK3 | 0.92431453 |
| 69 | WNK4 | 0.91829129 |
| 70 | TESK2 | 0.88232948 |
| 71 | PAK2 | 0.87932544 |
| 72 | PTK2B | 0.86771221 |
| 73 | PTK6 | 0.86190374 |
| 74 | ZAP70 | 0.84565624 |
| 75 | RPS6KA2 | 0.83044259 |
| 76 | PINK1 | 0.82834299 |
| 77 | SCYL2 | 0.81949725 |
| 78 | KSR1 | 0.81484496 |
| 79 | MAP2K1 | 0.81348605 |
| 80 | PTK2 | 0.80976141 |
| 81 | PKN2 | 0.79642908 |
| 82 | MAP3K14 | 0.79454116 |
| 83 | ARAF | 0.78868134 |
| 84 | PRKG2 | 0.77454145 |
| 85 | SGK2 | 0.77139716 |
| 86 | PDK3 | 0.75631386 |
| 87 | PDK4 | 0.75631386 |
| 88 | PLK2 | 0.73472440 |
| 89 | PDPK1 | 0.72477146 |
| 90 | BMX | 0.70812241 |
| 91 | TTN | 0.69436788 |
| 92 | FGR | 0.69242414 |
| 93 | MYLK | 0.68754094 |
| 94 | PRPF4B | 0.68621847 |
| 95 | ICK | 0.66658329 |
| 96 | CDK6 | 0.64728505 |
| 97 | TAOK2 | 0.64449803 |
| 98 | PRKCE | 0.64012445 |
| 99 | PRKCG | 0.63940384 |
| 100 | NME2 | 0.63916973 |
| 101 | PRKD2 | 0.63846863 |
| 102 | CSK | 0.63619302 |
| 103 | ABL2 | 0.63441414 |
| 104 | PDK2 | 0.63360581 |
| 105 | ROCK2 | 0.63300360 |
| 106 | CAMK2A | 0.62745591 |
| 107 | CAMK2G | 0.61863384 |
| 108 | DMPK | 0.61745402 |
| 109 | CAMK2D | 0.61489866 |
| 110 | CAMK1 | 0.59620029 |
| 111 | PRKD1 | 0.58459404 |
| 112 | STK11 | 0.58349809 |
| 113 | MAP3K7 | 0.57617918 |
| 114 | TBK1 | 0.57066671 |
| 115 | ROCK1 | 0.55976697 |
| 116 | STK10 | 0.55821680 |
| 117 | PDK1 | 0.55387876 |
| 118 | PRKCZ | 0.55149894 |
| 119 | TRPM7 | 0.54686603 |
| 120 | TYK2 | 0.54605374 |
| 121 | CSNK1G2 | 0.54190911 |
| 122 | CAMK2B | 0.53957634 |
| 123 | CDK14 | 0.53386904 |
| 124 | MAP3K1 | 0.52866131 |
| 125 | SGK1 | 0.52279092 |
| 126 | ALK | 0.52253710 |
| 127 | FGFR1 | 0.51764023 |
| 128 | MAP3K13 | 0.50659278 |
| 129 | CDC42BPA | 0.50333277 |
| 130 | MAP3K8 | 0.50258835 |
| 131 | PDGFRB | 0.49230504 |
| 132 | CAMK4 | 0.48650825 |
| 133 | YES1 | 0.48273964 |
| 134 | MARK2 | 0.48024733 |
| 135 | TAOK1 | 0.47972901 |
| 136 | FYN | 0.47801884 |
| 137 | SRC | 0.47646226 |
| 138 | PRKAA1 | 0.46935685 |
| 139 | BCR | 0.46698338 |
| 140 | ERBB2 | 0.46335710 |
| 141 | SIK2 | 0.45198275 |
| 142 | LRRK2 | 0.43543267 |
| 143 | MAP3K12 | 0.43352838 |
| 144 | FGFR3 | 0.42555992 |
| 145 | MATK | 0.42139509 |
| 146 | PIM2 | 0.41640640 |
| 147 | JAK1 | 0.38572069 |
| 148 | FLT3 | 0.38492788 |
| 149 | MAPK7 | 0.35652588 |
| 150 | NEK6 | 0.33974471 |
| 151 | MAP3K11 | 0.33849271 |
| 152 | GSK3A | 0.32269520 |
| 153 | RPS6KC1 | 0.29006200 |
| 154 | RPS6KL1 | 0.29006200 |
| 155 | CDK15 | 0.28789599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.53645621 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.16442904 |
| 3 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.96013723 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.34200293 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.27348507 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.01958467 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.99806126 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.95228014 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 1.94237707 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.82528202 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 1.74600479 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.69098881 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.66582323 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.63007929 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.59119691 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.57005953 |
| 17 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.55507183 |
| 18 | Adherens junction_Homo sapiens_hsa04520 | 1.54995614 |
| 19 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.51164836 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.49934008 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.46139274 |
| 22 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.46137915 |
| 23 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.42787828 |
| 24 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.42378953 |
| 25 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.38920452 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.38913182 |
| 27 | Bladder cancer_Homo sapiens_hsa05219 | 1.36577908 |
| 28 | Galactose metabolism_Homo sapiens_hsa00052 | 1.33841610 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.30213984 |
| 30 | Long-term potentiation_Homo sapiens_hsa04720 | 1.26838641 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.24947347 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.24207229 |
| 33 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.24091768 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.23807468 |
| 35 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.23284804 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.22074126 |
| 37 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.21959704 |
| 38 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21341525 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 1.20935543 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.20437973 |
| 41 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.17232056 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.13432607 |
| 43 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.08767046 |
| 44 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.08087215 |
| 45 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.07203005 |
| 46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.05650573 |
| 47 | Salmonella infection_Homo sapiens_hsa05132 | 1.05118415 |
| 48 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.04475991 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04121562 |
| 50 | Taste transduction_Homo sapiens_hsa04742 | 1.02547912 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.01661486 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01380481 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 1.00737598 |
| 54 | Thyroid cancer_Homo sapiens_hsa05216 | 1.00286907 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99800499 |
| 56 | Phagosome_Homo sapiens_hsa04145 | 0.99633535 |
| 57 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.99209439 |
| 58 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.98493305 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96919387 |
| 60 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95562896 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95502930 |
| 62 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.95444162 |
| 63 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.95366221 |
| 64 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.95346777 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.94988455 |
| 66 | Long-term depression_Homo sapiens_hsa04730 | 0.93872294 |
| 67 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.90981034 |
| 68 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89521671 |
| 69 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.88910301 |
| 70 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.88723063 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87757022 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87603993 |
| 73 | Gap junction_Homo sapiens_hsa04540 | 0.87462421 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86494395 |
| 75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86319706 |
| 76 | Shigellosis_Homo sapiens_hsa05131 | 0.86260754 |
| 77 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86047987 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.85691046 |
| 79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85133436 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.84729959 |
| 81 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.84428379 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84306045 |
| 83 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.84203278 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83767974 |
| 85 | Cocaine addiction_Homo sapiens_hsa05030 | 0.83321284 |
| 86 | Phototransduction_Homo sapiens_hsa04744 | 0.82425170 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81280192 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.79908072 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.79763878 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.79153755 |
| 91 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.76794948 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.76578897 |
| 93 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.76505572 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.76385307 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.75908387 |
| 96 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75812459 |
| 97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75187061 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.74714383 |
| 99 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74172920 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74124526 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73714287 |
| 102 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.72178675 |
| 103 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.71655153 |
| 104 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70852624 |
| 105 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70791417 |
| 106 | Melanogenesis_Homo sapiens_hsa04916 | 0.69266958 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69261764 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.68958684 |
| 109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.67946563 |
| 110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67344029 |
| 111 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67304769 |
| 112 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.67264687 |
| 113 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.66322090 |
| 114 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66318470 |
| 115 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63991193 |
| 116 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.63465086 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63004005 |
| 118 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62665272 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.60864283 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.60407377 |
| 121 | Tuberculosis_Homo sapiens_hsa05152 | 0.60108285 |
| 122 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59528645 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.59376125 |
| 124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.59275282 |
| 125 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.59256957 |
| 126 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58032042 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.57484195 |
| 128 | Prostate cancer_Homo sapiens_hsa05215 | 0.56821436 |
| 129 | Amoebiasis_Homo sapiens_hsa05146 | 0.56362968 |
| 130 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.56300944 |
| 131 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56141640 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.55774226 |
| 133 | Apoptosis_Homo sapiens_hsa04210 | 0.55263299 |
| 134 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55098631 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.54540341 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.53997618 |
| 137 | Tight junction_Homo sapiens_hsa04530 | 0.53897457 |
| 138 | Lysosome_Homo sapiens_hsa04142 | 0.53710827 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53079095 |
| 140 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52871205 |
| 141 | Platelet activation_Homo sapiens_hsa04611 | 0.52414785 |
| 142 | Mineral absorption_Homo sapiens_hsa04978 | 0.50632087 |
| 143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50503254 |
| 144 | Prion diseases_Homo sapiens_hsa05020 | 0.50314717 |
| 145 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49991698 |
| 146 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49512040 |
| 147 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49284374 |
| 148 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48793932 |
| 149 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48270132 |
| 150 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48207208 |
| 151 | Endocytosis_Homo sapiens_hsa04144 | 0.47505851 |
| 152 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46759565 |
| 153 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46512619 |
| 154 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.46483725 |
| 155 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45794568 |
| 156 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45720607 |
| 157 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45626952 |
| 158 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.44657483 |
| 159 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44608268 |
| 160 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.43994385 |

